Il y a eu 50 transactions d'initiés récentes enregistrées pour Cidara Therapeutics, Inc. (CDTX), dont 42 achats et 5 ventes. Le total des achats d'initiés s'élève à $30.15M et le total des ventes d'initiés à $96.81K.
Les initiés notables ayant une activité récente comprennent Burgess Daniel D, Ra Capital Management, L.p., Schroeder Theodore R. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — CDTX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2025-06-18 |
Burgess Daniel D |
Director |
Attribution de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Ra Capital Management, L.p. |
Director |
Attribution de RSU |
5,079 |
$21.31 |
$108.23K |
5,079 |
| 2025-06-18 |
Schroeder Theodore R |
Director |
Attribution de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Mineo Chrysa |
Director |
Attribution de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Bassler Bonnie L |
Director |
Attribution de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Resnick Joshua |
Director |
Attribution de RSU |
5,079 |
$21.31 |
$108.23K |
5,079 |
| 2025-06-18 |
Spencer Ryan |
Director |
Attribution de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Canale-theakston Carin |
Director |
Attribution de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Merson James |
Director |
Attribution de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-03 |
Mineo Chrysa |
Director |
Achat Informatif |
1,050 |
$23.44 |
$24.61K |
3,320 |
| 2025-06-02 |
Mineo Chrysa |
Director |
Achat Informatif |
2,270 |
$21.71 |
$49.28K |
2,270 |
| 2025-05-01 |
Davarpanah Nicole Negar |
Chief Medical Officer |
Inconnu |
30,000 |
$21.54 |
$646.2K |
- |
| 2025-05-01 |
Davarpanah Nicole Negar |
Chief Medical Officer |
Attribution de RSU |
20,000 |
$21.75 |
$435K |
20,000 |
| 2025-03-31 |
Stein Jeffrey |
President & CEO |
Attribution de RSU |
275,000 |
$21.54 |
$5.92M |
275,000 |
| 2025-03-31 |
Ward Shane |
COO & CLO |
Attribution de RSU |
25,000 |
- |
- |
39,674 |
| 2025-03-11 |
Ward Shane |
COO & CLO |
Vente Informative |
1,664 |
$21.96 |
$36.54K |
14,674 |
| 2025-03-11 |
Tari Leslie |
Chief Scientific Officer |
Vente Informative |
1,773 |
$21.96 |
$38.94K |
16,215 |
| 2025-02-24 |
Karbe Frank |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-02-24 |
Karbe Frank |
Chief Financial Officer |
Attribution de RSU |
57,500 |
- |
- |
57,500 |
| 2025-01-03 |
Ra Capital Management, L.p. |
Director |
Attribution de RSU |
22,200 |
$26.62 |
$590.96K |
22,200 |
| 2025-01-03 |
Resnick Joshua |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-01-03 |
Resnick Joshua |
Director |
Attribution de RSU |
22,200 |
$26.62 |
$590.96K |
22,200 |
| 2024-12-17 |
Burgess Daniel D |
Director |
Attribution de RSU |
20,500 |
$22.81 |
$467.61K |
20,500 |
| 2024-12-17 |
Schroeder Theodore R |
Director |
Attribution de RSU |
20,500 |
$22.81 |
$467.61K |
20,500 |
| 2024-12-17 |
Mineo Chrysa |
Director |
Attribution de RSU |
19,000 |
$22.81 |
$433.39K |
19,000 |
| 2024-12-17 |
Bassler Bonnie L |
Director |
Attribution de RSU |
16,000 |
$22.81 |
$364.96K |
16,000 |
| 2024-12-17 |
Canale-theakston Carin |
Director |
Attribution de RSU |
16,000 |
$22.81 |
$364.96K |
16,000 |
| 2024-11-26 |
Ra Capital Management, L.p. |
Director |
Attribution de RSU |
389,716 |
$14.91 |
$5.81M |
1,092,796 |
| 2024-09-30 |
Stein Jeffrey |
President & CEO |
Attribution de RSU |
560,888 |
$10.75 |
$6.03M |
560,888 |
| 2024-09-30 |
Ward Shane |
COO & CLO |
Attribution de RSU |
135,540 |
$10.75 |
$1.46M |
135,540 |
| 2024-09-30 |
Sandison Taylor |
Chief Medical Officer |
Attribution de RSU |
166,836 |
$10.75 |
$1.79M |
166,836 |
| 2024-09-30 |
Shah Preetam |
Chief Financial Officer |
Attribution de RSU |
130,087 |
$10.75 |
$1.4M |
130,087 |
| 2024-09-30 |
Tari Leslie |
Chief Scientific Officer |
Attribution de RSU |
150,224 |
$10.75 |
$1.61M |
150,224 |
| 2024-09-11 |
Sandison Taylor |
Chief Medical Officer |
Vente Informative |
924 |
$11.64 |
$10.75K |
23,067 |
| 2024-09-11 |
Tari Leslie |
Chief Scientific Officer |
Vente Informative |
909 |
$11.64 |
$10.58K |
17,788 |
| 2024-07-19 |
Ra Capital Management, L.p. |
Director |
Conversion (Vente) |
10,044 |
- |
- |
89,956 |
| 2024-07-18 |
Burgess Daniel D |
Director |
Attribution de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Ra Capital Management, L.p. |
Director |
Attribution de RSU |
2,125 |
$1.00 |
$2.13K |
2,125 |
| 2024-07-18 |
Schroeder Theodore R |
Director |
Attribution de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Mineo Chrysa |
Director |
Attribution de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Bassler Bonnie L |
Director |
Attribution de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Spencer Ryan |
Director |
Attribution de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Canale-theakston Carin |
Director |
Attribution de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Tadvalkar Laura |
Director |
Attribution de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Merson James |
Director |
Attribution de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Ra Capital Management, L.p. |
Director |
Attribution de RSU |
100,000 |
- |
- |
100,000 |
| 2024-07-18 |
Ra Capital Management, L.p. |
Director |
Attribution de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-06-07 |
Stein Jeffrey |
President & CEO |
Achat Informatif |
8,000 |
$13.21 |
$105.68K |
24,580 |
| 2024-04-26 |
Ra Capital Management, L.p. |
Director |
Attribution de RSU |
4,250 |
$12.63 |
$53.68K |
4,250 |
| 2024-04-26 |
Spencer Ryan |
Director |
Attribution de RSU |
4,250 |
$12.63 |
$53.68K |
4,250 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
